Piramal Pharma Ltd.
Snapshot View

View in App

Prices View details >>

67.82 -2.00 ▼-2.9%

24 March 2023, 04:01:00 PM
Volume: 198,836

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.piramal.com
Market Cap 8,093.09 Cr.
Enterprise Value(EV) 12,478.52 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 3.15 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) 21.53 Trailing Twelve Months Ending 2022-03
Industry PE 31.87 Trailing Twelve Months Ending 2022-03
Book Value / Share 55.03 Trailing Twelve Months Ending 2022-03
Price to Book Value 1.23 Calculated using Price: 67.82
Dividend Yield 1.45 Period Ending 2022-03
No. of Shares Subscribed 119.33 Cr. 1,193,318,500 Shares
FaceValue 10
Company Profile
No Company Profile found.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-2.86%
1 Week
+1.09%
1 Month
-17.69%
3 Month
-40.79%
6 Month
1 Year
2 Year
5 Year
10 Year

Ratios View Details >>

2 years 2021-03 2022-03
Return on Equity (%) 14.90 6.11
Return on Capital Employed (%) 13.06 7.10
Return on Assets (%) 7.76 3.21

Balance Sheet View Details >>

Particulars 3 years 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 5,605 6,697 6,672
Non Curr. Liab. 2,560 2,870 3,477
Curr. Liab. 2,591 3,118 3,188
Minority Int.
Equity & Liab. 10,756 12,685 13,337
Non Curr. Assets 7,007 8,533 9,023
Curr. Assets 3,749 4,152 4,313
Misc. Exp. not W/O
Total Assets 10,756 12,685 13,337

Profit Loss View Details >>

Particulars 2 years 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Net Sales 6,315 6,559
Other Income 164 276
Total Income 6,479 6,835
Total Expenditure -4,887 -5,609
PBIDT 1,592 1,225
Interest -163 -198
Depreciation -545 -586
Taxation -114 -109
Exceptional Items 18 -15
PAT 835 376
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 835 376
Adjusted EPS 8 3

Cash Flow View Details >>

Particulars 2 years 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 598 766
Cash Fr. Inv. -4,480 -1,812
Cash Fr. Finan. 3,977 794
Net Change 94 -251
Cash & Cash Eqvt 262 85

Shareholding Pattern View Details >>

2 Qtrs 2022-09 (%) 2022-12 (%)
Promoter 34.79 34.79
Public 65.21 65.21
Depository Receipts 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00

Announcements View Details >>

Thu, 23 Mar 2023
Disclosure Under Regulation 30 Read With Regulation 31A Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 As Amended ('SEBI Listing Regulations') - Application For Re-Classification From 'Promoter Group' Category To 'Public' Category Of Piramal Pharma Limited ('The Company')
Disclosure under Regulation 30 read with Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended (SEBI Listing Regulations) - Application for re-classification from Promoter Group category to Public category of Piramal Pharma Limited (the Company)
Thu, 23 Mar 2023
Disclosure Under Regulation 30 Read With Regulation 31A Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 As Amended ('SEBI Listing Regulations') -Re-Classification From 'Promoter Group' Category To 'Public' Category Of Piramal Pharma Limited ('The Company')
Disclosure under Regulation 30 read with Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended (SEBI Listing Regulations) -Re-classification from Promoter Group category to Public category of Piramal Pharma Limited (the Company)
Wed, 22 Mar 2023
Declaration Of Voting Results Of Postal Ballot Under Regulation 44(3) Of The SEBI(Listing Obligations And Disclosure Requirements) Regulations 2015 ('SEBI Listing Regulations')
Declaration of voting results of Postal Ballot under Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations)

Technical Scans View Details >>

Fri, 24 Mar 2023
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
Close Below Last Month Low Close Below Last Month Low
High Decrease in 1 Month High Decrease in 1 Month
High Decrease in 3 Months High Decrease in 3 Months
William %R Crossed -80 From Above William %R Crossed -80 From Above

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 233,407.31 972.80 -0.5%
Divi's Laboratories Ltd. 74,570.12 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. 74,317.23 4,462.75 +0.3%
Cipla Ltd. 70,787.11 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. 61,428.40 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. 51,367.56 1,517.75 -0.9%
Zydus Lifesciences Ltd. 48,636.41 480.50 -0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 55.42 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-12 31.11 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.39 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-12 26.83 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 80.33 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 61.81 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.60 480.50 -0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.22 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-12 5.99 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.38 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-12 3.12 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 9.96 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.06 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.82 480.50 -0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-03 0.04 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 480.50 -0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-03 13.10 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 480.50 -0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-03 13.10 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 480.50 -0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-03 21,763.34 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 480.50 -0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-03 2,559.47 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 480.50 -0.4%

FAQ's On Piramal Pharma Ltd.

What is Piramal Pharma share price?
Can I buy Piramal Pharma shares now?
What is the Dividend Yield of Piramal Pharma?
What is the Market Cap of Piramal Pharma?
What are the key metrics to analyse Piramal Pharma?
What is the 52 Week High and Low of Piramal Pharma?
What is the trend of Piramal Pharma share price?